← Insider Monitor
Anixa Biosciences Inc logo
ANIX

Anixa Biosciences Inc

Nasdaq · Pharmaceutical Preparations

1
Insider trades
0
Congress trades

Company Overview

A concise company profile alongside the latest public filing activity.

Anixa Biosciences is a biotechnology company developing therapeutics in the areas of cancer treatment and diagnostics, including chimeric antigen receptor (CAR) T-cell immunotherapy approaches for ovarian cancer and other solid tumors. It also works on early cancer detection technologies and vaccine research programs, often through collaborations with academic and research institutions.

Industry
Pharmaceutical Preparations
Headquarters
San Jose, CA
Exchange
Nasdaq

Company profile sourced from SEC filings.

Corporate Insider Trades

Open-market purchases and sales by directors, officers, and other company insiders.

InsiderTypeValueDate
KUMAR AMITChief Executive OfficerBuy$22KOct 22, 2026

Source: SEC EDGAR Form 4 filings

Congressional Trades

Recent disclosures by members of the U.S. House and Senate.

No recent congressional disclosures found for ANIX.

Source: Senate eFD and House Clerk STOCK Act disclosures

Get notable ANIX activity by email

Free alerts for the insider and congressional trades worth watching.

SMS is optional: we only save your number if you check the consent box and provide a valid number. US mobile numbers only.

SMS Terms and Privacy Policy.

By submitting your email address, you will receive a free subscription to the MySmarTrend e-letter, and offers from us and our affiliates that we think might interest you. You can unsubscribe at any time. Privacy Policy.

For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.